Distinct CSF biomarker-associated DNA methylation in Alzheimer’s disease and cognitively normal subjects
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource, 1 online resource.
- Sprache
-
Englisch
- Erschienen in
-
Distinct CSF biomarker-associated DNA methylation in Alzheimer’s disease and cognitively normal subjects ; volume:15 ; number:1 ; day:10 ; month:4 ; year:2023 ; pages:1-19 ; date:12.2023
Alzheimer's research & therapy ; 15, Heft 1 (10.4.2023), 1-19, 12.2023
- Urheber
-
Zhang, Wei
Young, Juan I.
Gomez, Lissette
Schmidt, Michael A.
Lukacsovich, David
Varma, Achintya
Chen, X. Steven
Martin, Eden R.
Wang, Lily
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13195-023-01216-7
- URN
-
urn:nbn:de:101:1-2023082509245926544296
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:52 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Zhang, Wei
- Young, Juan I.
- Gomez, Lissette
- Schmidt, Michael A.
- Lukacsovich, David
- Varma, Achintya
- Chen, X. Steven
- Martin, Eden R.
- Wang, Lily
- SpringerLink (Online service)
Ähnliche Objekte (12)
Accuracy of plasma Aβ40, Aβ42, and p-tau181 to detect CSF Alzheimer’s pathological changes in cognitively unimpaired subjects using the Lumipulse automated platform
Specific serum antibody binding to phosphorylated and non-phosphorylated tau in non-cognitively impaired, mildly cognitively impaired, and Alzheimer’s disease subjects: an exploratory study
Genetic data and cognitively defined late-onset Alzheimer’s disease subgroups
Decline in cognitively complex everyday activities accelerates along the Alzheimer’s disease continuum
CSF Presenilin-1 complexes are increased in Alzheimer’s disease
Levels of ADAM10 are reduced in Alzheimer’s disease CSF
Alzheimer’s disease CSF biomarkers: clinical indications and rational use
Cognitively impaired aged Octodon degus recapitulate major neuropathological features of sporadic Alzheimer’s disease
Decreased CSF clearance and increased brain amyloid in Alzheimer’s disease
CSF and plasma Aβ42/40 across Alzheimer’s disease continuum: comparison of two ultrasensitive Simoa ® assays targeting distinct amyloid regions
Musical Mnemonics in Cognitively Unimpaired Individuals and Individuals with Alzheimer’s Dementia: A Systematic Review
Dynamic changes of CSF clusterin levels across the Alzheimer’s disease continuum
Accuracy of plasma Aβ40, Aβ42, and p-tau181 to detect CSF Alzheimer’s pathological changes in cognitively unimpaired subjects using the Lumipulse automated platform
Specific serum antibody binding to phosphorylated and non-phosphorylated tau in non-cognitively impaired, mildly cognitively impaired, and Alzheimer’s disease subjects: an exploratory study
Genetic data and cognitively defined late-onset Alzheimer’s disease subgroups
Decline in cognitively complex everyday activities accelerates along the Alzheimer’s disease continuum
CSF Presenilin-1 complexes are increased in Alzheimer’s disease
Levels of ADAM10 are reduced in Alzheimer’s disease CSF
Alzheimer’s disease CSF biomarkers: clinical indications and rational use
Cognitively impaired aged Octodon degus recapitulate major neuropathological features of sporadic Alzheimer’s disease
Decreased CSF clearance and increased brain amyloid in Alzheimer’s disease
CSF and plasma Aβ42/40 across Alzheimer’s disease continuum: comparison of two ultrasensitive Simoa ® assays targeting distinct amyloid regions
Musical Mnemonics in Cognitively Unimpaired Individuals and Individuals with Alzheimer’s Dementia: A Systematic Review
Dynamic changes of CSF clusterin levels across the Alzheimer’s disease continuum
Accuracy of plasma Aβ40, Aβ42, and p-tau181 to detect CSF Alzheimer’s pathological changes in cognitively unimpaired subjects using the Lumipulse automated platform
Specific serum antibody binding to phosphorylated and non-phosphorylated tau in non-cognitively impaired, mildly cognitively impaired, and Alzheimer’s disease subjects: an exploratory study
Genetic data and cognitively defined late-onset Alzheimer’s disease subgroups
Decline in cognitively complex everyday activities accelerates along the Alzheimer’s disease continuum
CSF Presenilin-1 complexes are increased in Alzheimer’s disease
Levels of ADAM10 are reduced in Alzheimer’s disease CSF
Alzheimer’s disease CSF biomarkers: clinical indications and rational use
Cognitively impaired aged Octodon degus recapitulate major neuropathological features of sporadic Alzheimer’s disease
Decreased CSF clearance and increased brain amyloid in Alzheimer’s disease
CSF and plasma Aβ42/40 across Alzheimer’s disease continuum: comparison of two ultrasensitive Simoa ® assays targeting distinct amyloid regions
Musical Mnemonics in Cognitively Unimpaired Individuals and Individuals with Alzheimer’s Dementia: A Systematic Review